by Team JCW | Sep 18, 2025 | In the Spotlight, News & Recognition, Press Release
Mandala Medical Group highlights orthopedic oncologist’s founding role and continued contributions to musculoskeletal oncology education Morristown, NJ – Thursday, September 18, 2025 — Mandala Medical Group is proud to announce that internationally recognized...
by Team JCW | Sep 16, 2025 | Testimonials from Grateful Patients
When facing complex health challenges, the right physician can make all the difference. For Sandra Magnes, that physician has been Dr. James C. Wittig. Sandra speaks with unwavering conviction: “I trust Dr. James Wittig with my life!” Her words reflect not only the...
by Team JCW | Sep 11, 2025 | From Dr. Wittig’s Desk, News & Recognition
On the morning of September 11th, 2001, having begun my practice as an orthopedic oncologist at NYU Hospital for Joint Diseases and Bellevue Hospital less than two weeks before, I was called to service after two airplanes hijacked by terrorists took down the Twin...
by Team JCW | Sep 9, 2025 | From Dr. Wittig’s Desk, News & Recognition
By James C. Wittig, M.D. When we talk about cancer, much of the conversation focuses on the fight itself, the diagnosis, the treatment, and the obstacles that must be faced head-on with courage and resilience. But what is often overlooked, and just as important, is...
by Team JCW | Sep 9, 2025 | From Dr. Wittig’s Desk, News & Recognition
September 1, 2001, marked the start of a new chapter in my life. I had just begun my practice as an orthopedic oncologist at NYU Hospital for Joint Diseases and Bellevue Hospital. Ten days later, that chapter was forever altered. On the morning of September 11th, I...
by Team JCW | Sep 8, 2025 | In the Spotlight, News & Recognition, Sacred Patients, Signature Surgeries, Surgical Excellence
Ewing sarcoma is a rare, aggressive cancer that primarily strikes children and adolescents, yet it can present in infants, where it is exceptionally uncommon. U.S. registry data show an incidence of about 3 cases per 1,000,000 in people younger than 20, with rates...
